AstraZeneca PLC
1644.50
06-May-24 02:29:16
15 minutes delayed
Stocks
+10.50
+0.64%
Today's range
1634.00 - 1645.50
ISIN
N/A
Source
NASD.OMX SE
-
AstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer
04 Mar 2024 02:26:38 By NASDAQ US Markets
-
AstraZeneca: Voydeya Recommended For Approval In The EU By CHMP - Quick Facts
26 Feb 2024 01:56:02 By NASDAQ US Markets
-
AstraZeneca Prices $5bln Four Tranche Notes Offering
22 Feb 2024 02:24:41 By NASDAQ US Markets
-
20 Feb 2024 11:22:37 By NASDAQ Stocks
-
20 Feb 2024 11:17:15 By NASDAQ US Markets
-
Ex-Dividend Reminder: Avista, ONE Gas and AstraZeneca
20 Feb 2024 10:29:26 By NASDAQ Stocks
-
Ex-Dividend Reminder: Avista, ONE Gas and AstraZeneca
20 Feb 2024 10:25:27 By NASDAQ US Markets
-
AstraZeneca's Tagrisso With Chemotherapy Approved In US To Treat Lung Cancer
19 Feb 2024 03:46:28 By NASDAQ US Markets
-
AstraZeneca Enters Oversold Territory
12 Feb 2024 12:12:53 By NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
08 Feb 2024 15:26:03 By NASDAQ US Markets
-
Ionis Says Eplontersen Got Fast Track Status To Treat Transthyretin-mediated Amyloid Cardiomyopathy
08 Feb 2024 07:43:49 By NASDAQ US Markets
-
AstraZeneca Q4 Profit Rises; Revenue Ex COVID-19 Up 16% At CER
08 Feb 2024 01:49:12 By NASDAQ US Markets
-
AstraZeneca's (AZN) sBLA for Enhertu Gets FDA's Priority Tag
30 Jan 2024 08:02:12 By NASDAQ Stocks
-
AstraZeneca: FDA Grants ENHERTU Priority Review For Metastatic HER2-Positive Solid Tumors
29 Jan 2024 07:32:09 By NASDAQ US Markets
-
AZN March 8th Options Begin Trading
25 Jan 2024 10:49:47 By NASDAQ Stocks
-
AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma
22 Jan 2024 06:32:47 By NASDAQ US Markets
-
Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial
08 Jan 2024 07:09:47 By NASDAQ US Markets
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 10:38:29 By NASDAQ Stocks
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 10:34:42 By NASDAQ US Markets
-
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
02 Jan 2024 08:45:15 By NASDAQ US Markets